Detalles de la búsqueda
1.
Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases.
Int J Cancer
; 150(9): 1537-1548, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994972
2.
Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
Int J Cancer
; 148(7): 1665-1675, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33320961
3.
Enhanced Performance of DNA Methylation Markers by Simultaneous Measurement of Sense and Antisense DNA Strands after Cytosine Conversion.
Clin Chem
; 66(7): 925-933, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32460325
4.
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment.
Nat Med
; 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38877116
5.
Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study.
Eur J Cancer
; 163: 163-176, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074652
6.
[Circulating tumour DNA in the treatment of cancer].
Ugeskr Laeger
; 183(32)2021 08 09.
Artículo
en Danés
| MEDLINE | ID: mdl-34378526
7.
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Clin Epigenetics
; 11(1): 158, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727158
8.
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.
Mol Oncol
; 12(4): 545-560, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29465788
Resultados
1 -
8
de 8
1
Próxima >
>>